Valerio Therapeutics appoints Gilles Besin CEO effective July 2026
Valerio Therapeutics named Gilles Besin chief executive officer, effective July 2026, replacing Julien Miara.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Valerio Therapeutics named Gilles Besin chief executive officer, effective July 2026, replacing Julien Miara.